Adtalem Global Education (NYSE:CVSA) CFO Sells $392,689.00 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,900 shares of the stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $135.41, for a total value of $392,689.00. Following the completion of the transaction, the chief financial officer directly owned 52,906 shares of the company’s stock, valued at $7,164,001.46. This represents a 5.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

CVSA stock traded down $0.68 during midday trading on Friday, hitting $130.64. The stock had a trading volume of 301,004 shares, compared to its average volume of 347,922. The stock has a market cap of $4.45 billion, a price-to-earnings ratio of 20.35, a price-to-earnings-growth ratio of 0.99 and a beta of 0.62. The stock’s 50-day moving average price is $124.72. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36.

Adtalem Global Education (NYSE:CVSA) last announced its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Research analysts predict that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Finally, Truist Financial increased their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.